Express Scripts (ESRX) Tops Q2 EPS by 4c, Raises FY EPS Guidance

Express Scripts (NASDAQ: ESRX) reported Q2 EPS of $1.44, $0.04 better than the analyst estimate of $1.40. Revenue for the quarter came in at $25.45 billion versus the consensus estimate of $26.15 billion.

Express Scripts sees FY2015 EPS of $5.46-$5.54, versus prior guidance of $5.37-$5.47 and the consensus of $5.44.

For earnings history and earnings-related data on Express Scripts (ESRX) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Stardust Power (SDST) Tops Q2 EPS by 1c